Controlling Scabies in institutional settings: A review of medications, treatment models, and implementation

American Journal of Clinical Dermatology

Volumn 5, Issue 1, 2004, Pages 31-37

  Scheinfeld, Noah ^a,b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLETHRIN; BENZYL BENZOATE; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN;

ANAMNESIS; CLINICAL FEATURE; CONTACT DERMATITIS; DISINFECTION; DRUG APPROVAL; DRUG DOSE REGIMEN; EPIDEMIC; FECES ANALYSIS; HEALTH CARE COST; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; IRRITANT DERMATITIS; MORBIDITY; NEUROTOXICITY; NURSING HOME; PAPULE; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PUSTULE; REVIEW; SCABIES; SIDE EFFECT; SKIN NODULE; TREATMENT FAILURE; TREATMENT OUTCOME; URTICARIA;

CROSS INFECTION; HUMANS; INFECTION CONTROL; IVERMECTIN; LINDANE; NURSING HOMES; PERMETHRIN; PRACTICE GUIDELINES; SCABIES;

EID: 1542343880     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200405010-00005     Document Type: Review

References (34)

1. Problems in nursing homes for the aged. Scabies returns: massively! Krankenpfl J 2002; 40 (1-2): 38-9
2. Tan HH, Goh CL. Parasitic skin infections in the elderly: recognition and drug treatment. Drugs Aging 2001; 18 (3): 165-76
3. Chouela E, Abeldano A, Pellerano G, et al. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9-18
4. Haag ML, Brozena SJ, Fenske NA. Attack of the scabies: what to do when an outbreak occurs. Geriatrics 1993; 48: 45-6, 51-3
5. Levine N. Scaly, crusted papules: these pruritic lesions can become epidemic in nursing home residents [letter]. Geriatrics 1997; 52: 90
6. Moberg SA, Lowhagen GB, Hersle KS. An epidemic of scabies with unusual features and treatment resistance in a nursing home. J Am Acad Dermatol 1984; 11: 242-4
7. Parish LC, Witkowski JA, Millikan LE. Scabies in the extended care facility: revisited. Int J Dermatol 1991; 30: 703-6
8. Konishi N, Suzuki K, Tokura Y, et al. Bullous eruption associated with scabies: evidence for scabetic induction of true bullous pemphigoid. Acta Derm Venereol 2000; 80 (4): 281-3
9. Hurwitz S. Scabies in babies. Am J Dis Child 1973; 126 (2): 226-8
10. Parish LC, Millikan LE, Witkowski JA, et al. Scabies in the extended care facility. Int J Dermatol 1983; 22: 380-2
11. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis 2002; 35 Suppl. 2: S146-51
12. del Giudice P. Ivermectin in scabies. Curr Opin Infect Dis 2002; 15: 123-6
13. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996; 14 (6): 386-93
14. Franz TJ, Lehman PA, Franz SF, et al. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996; 132: 901-5
15. Solomon BA, Haut SR, Carr EM, et al. Neurotoxic reaction to lindane in an HIV-seropositive patient. An old medication's new problem. J Fam Pract 1995; 40 (3): 291-6
16. Buffet M, Dupin N. Current treatments for scabies. Fundam Clin Pharmacol 2003; 17 (2): 217-25
17. Bigby M. A systematic review of the treatment of scabies. Arch Dermatol 2000; 136: 387-9
18. Millership S, Readman R, Bracebridge S. Use of ivermectin, given orally, to control scabies in homes for the elderly mentally ill. Commun Dis Public Health 2002; 5: 144-6
19. Haas N, Henz BM, Ohlendorf D. Is a single oral dose of ivermectin sufficient in crusted scabies? Int J Dermatol 2001; 40: 599-600
20. Elgart GW, Meinking TL. Ivermectin. Dermatol Clin 2003; 21 (2): 277-82
21. Yonkosky D, Ladia L, Gackenheimer L, et al. Scabies in nursing homes: an eradication program with permethrin 5% cream. J Am Acad Dermatol 1990; 23: 1133-6
22. Robles Garcia M, de la Lama Lopez-Areal J, Avellaneda Martinez C, et al. Nosocomial scabies outbreak. Rev Clin Esp 2000; 200: 538-42
23. Wilson MM, Philpott CD, Breer WA. Atypical presentation of scabies among nursing home residents. J Gerontol A Biol Sci Med Sci 2001; 56: M424-7
24. Dannaoui E, Kiazand A, Piens M, et al. Use of ivermectin for the management of scabies in a nursing home. Eur J Dermatol 1999; 9: 443-5
25. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997; 38: 137-40
26. Estes SA, Estes J. Therapy of scabies: nursing homes, hospitals, and the homeless. Semin Dermatol 1993; 12: 26-33
27. Paasch U, Haustein UF. Treatment of endemic scabies with allethrin, permethrin and ivermectin: evaluation of a treatment strategy. Hautarzt 2001; 52 (1): 31-7
28. Paasch U, Haustein UF. Management of endemic outbreaks of scabies with allethrin, permethrin, and ivermectin. Int J Dermatol 2000; 39: 463-70
29. Andersen BM, Haugen H, Rasch M, et al. Outbreak of scabies in Norwegian nursing homes and home care patients: control and prevention. J Hosp Infect 2000; 45: 160-4
30. Xavier G. Public relations. Nurs Times 1998; 94: 74-5
31. Paules SJ, Levisohn D, Heffron W. Persistent scabies in nursing home patients. J Fam Pract 1993; 37: 82-6
32. Jack M. Scabies outbreak in an extended care unit: a positive outcome. Can J Infect Control 1993; 8: 11-3
33. Jimenez-Lucho VE, Fallon F, Caputo C, et al. Role of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am J Infect Control 1995; 23: 44-9
34. Arlian LG, Estes SA, Vyszenski-Moher DL. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J Am Acad Dermatol 1988; 19: 806-11